Newsmeme!
Discover News you didn't know existed
Abraxis BioScience, Inc. (NASDAQ:ABII), an integrated biotechnology company, announced the listing of ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) 100 mg in Quebec for the treatment of metastatic breast cancer with a recommendation from the Quebec Conseil du Médicament and approval from the Quebec Ministry of Health.
Polymer laminate technology is an enabling platform for rapid prototyping of single-use, lab-on-a-chip devices that are revolutionizing IVDs.
Optimer Pharma: Promising Year Ahead
LOS ANGELES & TORONTO----Abraxis BioScience, Inc. , an integrated biotechnology company, today announced the listing of ABRAXANE® for Injectable Suspension 100 mg in Quebec for the treatment of metastatic breast cancer with a recommendation from the Quebec Conseil du Medicament and approval from the Quebec Ministry of Health.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |